Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ingo Sabatschus"'
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 10, Iss 6 (2022)
Introduction Painful diabetic peripheral neuropathy (PDPN), a common complication of diabetes mellitus, is challenging to treat. Efficacy and tolerability of the topical lidocaine 700 mg medicated plaster (LMP) and well-established first-line oral me
Externí odkaz:
https://doaj.org/article/e0fd7f945d7c496797825034af977d21
Publikováno v:
Pain management. 12(6)
Aim: To compare the effectiveness and tolerability of the lidocaine 700 mg medicated plaster (LMP) and oral first-line medications (OM) for the treatment of postsurgical neuropathic pain (PSNP) in routine clinical practice. Patients & methods: Data f
Autor:
Ingo Sabatschus, Arne Sprünken, Mariëlle Eerdekens, Irmgard Bösl, Marlou Prevoo, Michael Forstner, Oliver Galm
Publikováno v:
Pain and therapy. 11(1)
Peripheral neuropathic pain (PNP) is difficult to treat. Several oral drugs are recommended as first-line treatments. Nevertheless, many patients cannot obtain sufficient pain relief or do not tolerate systemically active treatments. Topical treatmen
Publikováno v:
Pain management. 12(2)
Aim: To provide real-world evidence for the effectiveness and tolerability of lidocaine 700 mg medicated plaster (LMP) compared with oral systemic first-line medications (OSM) in postherpetic neuralgia treatment. Patients & methods: Retrospective coh
Autor:
Vanessa Huertas Carrera, Steve Ryder, Dhwani Shah, Bettina Buchheister, Irmgard Boesl, Gill Worthy, Ingo Sabatschus, Titas Buksnys, Hiltrud Liedgens, Nigel Armstrong, Jos Kleijnen, Stephanie L. Swift, Caro Noake
Publikováno v:
Current Medical Research and Opinion. 36:101-115
Objective: Neuropathic pain prevalence is estimated between 7% and 10% of the population. International guidelines recommend a variety of drugs at different therapy lines for pain relief. However, side effect profiles, for example, prompted the UK go
Autor:
Ingo Sabatschus, Jiří Létal, E. Dietlind Koch, Sofia Kapanadze, Marie-Henriette Eerdekens, Georg Kralidis, Sam H Ahmedzai
Publikováno v:
Journal of pain and symptom management. 58(3)
Context Pain is one of the most prevalent symptoms associated with cancer. Strong opioids are commonly used in the analgesic management of the disease, but carry the risk of severe side effects. Cebranopadol is a first-in-class drug candidate, combin
Autor:
Christoph Stellbrink, Jannie Ausma, Dirk Frechen, Ulrich Schotten, Ingo Sabatschus, Miriam Vogel, Maurits A. Allessie, Friedrich Schoendube, Peter Hanrath
Publikováno v:
Circulation. 103(5)
Background —After cardioversion of atrial fibrillation (AF), the contractile function of the atria is temporarily impaired. Although this has significant clinical implications, the underlying cellular mechanisms are poorly understood. Methods and R